MedDiet in Kidney Transplant Recipients
MedDiet_KT
6-Week Mediterranean Diet Intervention on Dietary Adherence, Body Composition, and Physical Function in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
1 other identifier
interventional
23
1 country
1
Brief Summary
In recent years, increasing attention has been directed toward the role of diet and lifestyle factors in influencing graft function and patient survival after kidney transplantation (KT). Among the dietary patterns investigated, the Mediterranean diet (MedDiet) is among most studied diets in KT recipients. Data from observational studies show that greater adherence to the MedDiet is beneficial in kidney transplant recipients and is associated with improved lipid profile, lower oxidative stress, less frequent new-onset diabetes mellitus after transplantation, metabolic syndrome, better kidney function, and mortality. Unfortunately, adherence to MedDiet in kidney transplant recipients is low, and ranges between 25 % and 44.7%. Data from a Dutch cross-sectional study showed that higher levels of food literacy are associated with better adherence to MedDiet. Nevertheless, evidence from randomized dietary interventions aimed at improving MedDiet adherence in this population remains limited. Therefore, the aim of our pilot randomized controlled trial was to evaluate whether a six-week MedDiet intervention could improve adherence to the Mediterranean dietary pattern, assessed using the Mediterranean Diet Adherence Screener (MEDAS), and to explore the effects of MedDiet on body composition and physical function. We conducted an interventional, randomized study at the Kidney Transplantation Centre, Department of Nephrology, University Medical Centre Ljubljana. The intervention duration was six weeks and was performed by a Master's student in nutrition. We included kidney transplant recipients undergoing regular follow-up at the Kidney Transplantation Centre. Patients were invited to participate verbally via telephone contact one week prior to their scheduled physician appointment. Participation was voluntary and confirmed by a signed informed consent. The following exclusion criteria were applied: body mass index (BMI) \> 25 kg/m², age \> 45 years, female sex, serum creatinine \> 250 µmol/L, a MEDAS score ≥ 10 points, and systolic blood pressure \> 160 mmHg. Patients were randomized to the intervention and control group. The primary study outcome was the MEDAS score. Secondary outcomes were lean tissue index (LTI; kg/m²), fat tissue index (FTI; kg/m²), handgrip strength (kg), and chair-stand performance (number of repetitions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
July 1, 2026
6 months
July 28, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mediterranean Diet Adherence Screener (MEDAS)
adherence to the Mediterranean Diet was measured using the MEDAS before and after the 6 week intervention
6 weeks
Secondary Outcomes (4)
lean tissue index (LTI; kg/m²)
6 weeks
fat tissue index (FTI; kg/m²)
6 weeks
handgrip strength (kg)
6 weeks
chair-stand test
6 weeks
Study Arms (2)
Intervention (MedDiet) group
EXPERIMENTALMed Diet group
Control arm
NO INTERVENTIONNo specific dietary intervention
Interventions
Eligibility Criteria
You may qualify if:
- years old
- male
- kidney transplant recipient
You may not qualify if:
- body mass index (BMI) \> 25 kg/m²
- age \> 45 years
- female sex
- serum creatinine \> 250 µmol/L,
- a MEDAS score ≥ 10 points, and systolic blood pressure \> 160 mmHg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMC Ljubljana
Ljubljana, 1000, Slovenia
Related Publications (3)
Billany RE, Bishop NC, Castle EM, Graham-Brown MPM, Greenwood SA, Lightfoot CJ, Wilkinson TJ. Physical activity interventions in adult kidney transplant recipients: an updated systematic review and meta-analysis of randomized controlled trials. Ren Fail. 2025 Dec;47(1):2480246. doi: 10.1080/0886022X.2025.2480246. Epub 2025 Mar 27.
PMID: 40148080BACKGROUNDYing T, Shi B, Kelly PJ, Pilmore H, Clayton PA, Chadban SJ. Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant. J Am Soc Nephrol. 2020 Dec;31(12):2887-2899. doi: 10.1681/ASN.2020050566. Epub 2020 Sep 9.
PMID: 32908001BACKGROUNDTonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, Klarenbach S, Gill J. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011 Oct;11(10):2093-109. doi: 10.1111/j.1600-6143.2011.03686.x. Epub 2011 Aug 30.
PMID: 21883901RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nephrology Specialist
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 3, 2026
Study Start
May 1, 2023
Primary Completion
October 31, 2023
Study Completion
January 1, 2024
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share